ATE542904T1 - Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen - Google Patents
Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationenInfo
- Publication number
- ATE542904T1 ATE542904T1 AT02770322T AT02770322T ATE542904T1 AT E542904 T1 ATE542904 T1 AT E542904T1 AT 02770322 T AT02770322 T AT 02770322T AT 02770322 T AT02770322 T AT 02770322T AT E542904 T1 ATE542904 T1 AT E542904T1
- Authority
- AT
- Austria
- Prior art keywords
- translational modifications
- post
- mammalian cells
- present
- proteinaceous molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL2001/000792 WO2003050286A1 (en) | 2001-10-29 | 2001-10-29 | Methods and means for producing proteins with predetermined post-translational modifications |
PCT/NL2002/000257 WO2003089468A1 (en) | 2002-04-19 | 2002-04-19 | Methods and means for producing proteins with predetermined post-translational modifications |
PCT/NL2002/000686 WO2003038100A1 (en) | 2001-10-29 | 2002-10-29 | Methods and means for producing proteins with predetermined post-translational modifications |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE542904T1 true ATE542904T1 (de) | 2012-02-15 |
Family
ID=26642018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02770322T ATE542904T1 (de) | 2001-10-29 | 2002-10-29 | Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen |
Country Status (14)
Country | Link |
---|---|
US (3) | US7304031B2 (de) |
EP (2) | EP2292770B1 (de) |
JP (1) | JP4583029B2 (de) |
CN (1) | CN100347306C (de) |
AT (1) | ATE542904T1 (de) |
AU (1) | AU2002335585B2 (de) |
BR (1) | BR0213402A (de) |
CA (2) | CA2465007C (de) |
DK (1) | DK1440157T3 (de) |
EA (2) | EA008220B1 (de) |
ES (1) | ES2381104T3 (de) |
IL (3) | IL161674A (de) |
NO (1) | NO20042209L (de) |
WO (1) | WO2003038100A1 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE278794T1 (de) | 1995-06-15 | 2004-10-15 | Crucell Holland Bv | Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie |
US8236561B2 (en) | 1999-04-15 | 2012-08-07 | Crucell Holland B.V. | Efficient production of IgA in recombinant mammalian cells |
US7604960B2 (en) | 1999-04-15 | 2009-10-20 | Crucell Holland B.V. | Transient protein expression methods |
US6855544B1 (en) | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
WO2003048348A2 (en) | 2001-12-07 | 2003-06-12 | Crucell Holland B.V. | Production of viruses, viral isolates and vaccines |
US20050164386A1 (en) * | 1999-04-15 | 2005-07-28 | Uytdehaag Alphonsus G. | Overexpression of enzymes involved in post-translational protein modifications in human cells |
US7297680B2 (en) * | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
US7527961B2 (en) | 1999-11-26 | 2009-05-05 | Crucell Holland B.V. | Production of vaccines |
US7192759B1 (en) | 1999-11-26 | 2007-03-20 | Crucell Holland B.V. | Production of vaccines |
US7521220B2 (en) | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
US20030072737A1 (en) | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
US7767643B2 (en) | 2000-12-29 | 2010-08-03 | The Kenneth S. Warren Institute, Inc. | Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
CA2465007C (en) * | 2001-10-29 | 2012-01-17 | Crucell Holland B.V. | Methods and means for producing proteins with predetermined post-translational modifications |
US8524477B2 (en) * | 2002-10-29 | 2013-09-03 | Crucell Holland B.V. | Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus E1A protein, and proteins obtained thereby |
NZ549776A (en) * | 2004-03-17 | 2009-07-31 | Crucell Holland Bv | Assay for the separation and quantification of hemagglutinin antigens |
CA2595676A1 (en) * | 2005-01-25 | 2006-08-03 | Apollo Life Sciences Limited | Molecules and chimeric molecules thereof |
US20100040581A1 (en) * | 2005-06-01 | 2010-02-18 | Niigata Tlo Corporation | Epo derivative-containing therapeutic agents for blood-related diseases |
AR053416A1 (es) * | 2005-11-10 | 2007-05-09 | Protech Pharma S A | Combinacion de glicoisoformas para el tratamiento o prevencion de la septicemia, linea celular transgenica productora de glicoformas de eritropoyetina, composicion farmaceutica que comprende a dicha combinacion, procedimientos para obtener la linea celular, procedimiento para producir dicha combinac |
AU2006316838B2 (en) * | 2005-11-15 | 2012-04-12 | Glycofi, Inc | Production of glycoproteins with reduced O-glycosylation |
US7642078B2 (en) | 2005-12-28 | 2010-01-05 | Crucell Holland B.V. | Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus E1A protein, and proteins obtained thereby |
US20150038413A1 (en) | 2006-02-03 | 2015-02-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US7553940B2 (en) * | 2006-02-03 | 2009-06-30 | Modigene Inc | Long-acting EPO polypeptides and derivatives thereof and methods thereof |
US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US10351615B2 (en) | 2006-02-03 | 2019-07-16 | Opko Biologics Ltd. | Methods of treatment with long-acting growth hormone |
US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
WO2007098548A1 (en) * | 2006-03-01 | 2007-09-07 | Apollo Life Sciences Limited | A molecule and chimeric molecules thereof |
CA2654154A1 (en) | 2006-06-07 | 2007-12-13 | The University Of Tokushima | Treatment of ischemic diseases using erythropoietin |
EP2057997A4 (de) | 2006-08-22 | 2012-11-07 | Chugai Pharmaceutical Co Ltd | Mittel zur prävention und/oder behandlung von peripherer neuropathie |
AR065613A1 (es) | 2007-03-09 | 2009-06-17 | Chugai Pharmaceutical Co Ltd | Agentes de proteccion para organos transplantados |
BRPI0810065A2 (pt) | 2007-04-16 | 2020-01-14 | Momenta Pharmaceuticals Inc | caracterização de n-glicanos usando exoglicosidases |
TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
US8138092B2 (en) | 2009-01-09 | 2012-03-20 | Lam Research Corporation | Spacer formation for array double patterning |
US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
TWI604850B (zh) | 2009-10-05 | 2017-11-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
JP6087338B2 (ja) | 2011-03-31 | 2017-03-01 | フェリング ベスローテン フェンノートシャップ | 医薬製剤 |
EP2773964A4 (de) * | 2011-11-03 | 2015-06-24 | Stc Biolog Inc | Verfahren zur bestimmung der pharmakologischen eigenschaften rekombinanter proteine |
MY167814A (en) | 2012-04-19 | 2018-09-26 | Opko Biologics Ltd | Long-acting oxyntomodulin variants and methods of producing same |
KR102341581B1 (ko) | 2012-11-20 | 2021-12-21 | 옵코 바이오로직스 리미티드 | 생식샘자극 호르몬 카복시 말단 펩타이드들과 부착하여 폴리펩타이드들의 유체역학적 부피를 증가시키는 방법 |
US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
US20180180626A1 (en) * | 2014-07-01 | 2018-06-28 | Stc Biologics, Inc. | A method for development of recombinant proteins with fingerprint like similarity to the reference product |
WO2016203482A2 (en) | 2015-06-19 | 2016-12-22 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US20190177385A1 (en) * | 2016-07-12 | 2019-06-13 | Hexal Ag | Glycoprotein with reduced acetylation rate of sialic acid residues |
JP7046173B2 (ja) * | 2017-10-11 | 2022-04-01 | エランコ・ユーエス・インコーポレイテッド | ブタg-csf変異体とその使用 |
CN111514279B (zh) * | 2020-06-16 | 2023-07-18 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | 神经营养因子3在制备治疗男性性腺功能减退症的药物中的应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991005867A1 (en) | 1989-10-13 | 1991-05-02 | Amgen Inc. | Erythropoietin isoforms |
US5789247A (en) * | 1994-04-01 | 1998-08-04 | Ballay; Annick | Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
ATE278794T1 (de) | 1995-06-15 | 2004-10-15 | Crucell Holland Bv | Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie |
US6783980B2 (en) * | 1995-06-15 | 2004-08-31 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
ES2239387T3 (es) * | 1997-03-27 | 2005-09-16 | The University Of British Columbia | Vectores de expresion de insecto. |
CA2221819A1 (en) | 1997-03-27 | 1998-09-27 | Thomas A. Gigliatti | Insect expression vectors |
US6929946B1 (en) * | 1998-11-20 | 2005-08-16 | Crucell Holland B.V. | Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
EA004766B1 (ru) | 1999-04-13 | 2004-08-26 | Дзе Кеннет С. Уоррен Инститьют, Инк. | Модуляция функции возбуждаемых тканей за счет периферического введения эритропоэтина |
ATE536417T1 (de) | 1999-04-15 | 2011-12-15 | Crucell Holland Bv | Herstellung von rekombinanten proteinen in einer menschlichen zelle mit mindestens einem e1 adenovirus protein |
US6855544B1 (en) * | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
US7297680B2 (en) * | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
US20050164386A1 (en) * | 1999-04-15 | 2005-07-28 | Uytdehaag Alphonsus G. | Overexpression of enzymes involved in post-translational protein modifications in human cells |
US6913922B1 (en) * | 1999-05-18 | 2005-07-05 | Crucell Holland B.V. | Serotype of adenovirus and uses thereof |
FI109811B (fi) * | 2000-09-26 | 2002-10-15 | Medicel Oy | Menetelmä GDP-L-fukoosin valmistamiseksi ja menetelmässä käytettäviä välineitä |
DE10056136A1 (de) | 2000-11-07 | 2002-05-16 | Nemod New Modalities | Verwendung von Schwangerschaftsproteinen, Liposomen, nativen Muzin-Fragmenten und Mimikry-Verbindungen zur Behandlung und Prophylaxe von entzündlichen Erkrankungen, zur Verhinderung der Metastasierung und zur Prophylaxe von Tumorerkrankungen |
US7473767B2 (en) | 2001-07-03 | 2009-01-06 | The Institute For Systems Biology | Methods for detection and quantification of analytes in complex mixtures |
ES2411007T3 (es) * | 2001-10-10 | 2013-07-04 | Novo Nordisk A/S | Remodelación y glicoconjugación de péptidos |
CA2465007C (en) * | 2001-10-29 | 2012-01-17 | Crucell Holland B.V. | Methods and means for producing proteins with predetermined post-translational modifications |
ATE514717T1 (de) * | 2002-07-18 | 2011-07-15 | Merus B V | Rekombinante produktion von antikörpermischungen |
NZ549776A (en) * | 2004-03-17 | 2009-07-31 | Crucell Holland Bv | Assay for the separation and quantification of hemagglutinin antigens |
US7183371B2 (en) * | 2004-11-01 | 2007-02-27 | General Electric Company | Method for making polycarbonate |
US20080139608A1 (en) * | 2006-12-06 | 2008-06-12 | Universiteit Leiden | 2,6,8, Trisubstituted 1-deazapurines and their different uses |
-
2002
- 2002-10-29 CA CA2465007A patent/CA2465007C/en not_active Expired - Fee Related
- 2002-10-29 AT AT02770322T patent/ATE542904T1/de active
- 2002-10-29 CA CA2756610A patent/CA2756610C/en not_active Expired - Fee Related
- 2002-10-29 BR BR0213402-0A patent/BR0213402A/pt not_active IP Right Cessation
- 2002-10-29 JP JP2003540365A patent/JP4583029B2/ja not_active Expired - Fee Related
- 2002-10-29 EP EP10177590.6A patent/EP2292770B1/de not_active Expired - Lifetime
- 2002-10-29 EA EA200400605A patent/EA008220B1/ru not_active IP Right Cessation
- 2002-10-29 EA EA200602163A patent/EA012340B1/ru not_active IP Right Cessation
- 2002-10-29 AU AU2002335585A patent/AU2002335585B2/en not_active Ceased
- 2002-10-29 DK DK02770322.2T patent/DK1440157T3/da active
- 2002-10-29 CN CNB028216903A patent/CN100347306C/zh not_active Expired - Fee Related
- 2002-10-29 US US10/494,140 patent/US7304031B2/en not_active Expired - Fee Related
- 2002-10-29 WO PCT/NL2002/000686 patent/WO2003038100A1/en active Application Filing
- 2002-10-29 ES ES02770322T patent/ES2381104T3/es not_active Expired - Lifetime
- 2002-10-29 EP EP02770322A patent/EP1440157B1/de not_active Expired - Lifetime
-
2004
- 2004-04-29 IL IL161674A patent/IL161674A/en not_active IP Right Cessation
- 2004-05-28 NO NO20042209A patent/NO20042209L/no not_active Application Discontinuation
-
2007
- 2007-01-24 US US11/657,202 patent/US7785833B2/en not_active Expired - Fee Related
- 2007-08-01 US US11/888,776 patent/US7696157B2/en not_active Expired - Fee Related
-
2009
- 2009-10-21 IL IL201673A patent/IL201673A/en not_active IP Right Cessation
- 2009-10-21 IL IL201674A patent/IL201674A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2465007A1 (en) | 2003-05-08 |
US7785833B2 (en) | 2010-08-31 |
DK1440157T3 (da) | 2012-05-07 |
CN100347306C (zh) | 2007-11-07 |
BR0213402A (pt) | 2004-10-13 |
WO2003038100A1 (en) | 2003-05-08 |
IL201673A (en) | 2013-10-31 |
EP1440157B1 (de) | 2012-01-25 |
EP1440157A1 (de) | 2004-07-28 |
EA012340B1 (ru) | 2009-10-30 |
US20080032922A1 (en) | 2008-02-07 |
CN1578838A (zh) | 2005-02-09 |
JP2005507426A (ja) | 2005-03-17 |
IL201674A (en) | 2013-10-31 |
EP2292770A3 (de) | 2012-12-19 |
JP4583029B2 (ja) | 2010-11-17 |
EP2292770A2 (de) | 2011-03-09 |
US20070117742A1 (en) | 2007-05-24 |
US7696157B2 (en) | 2010-04-13 |
EA008220B1 (ru) | 2007-04-27 |
EA200602163A1 (ru) | 2007-04-27 |
EP2292770B1 (de) | 2014-11-26 |
IL161674A (en) | 2014-06-30 |
US20050164917A1 (en) | 2005-07-28 |
AU2002335585B2 (en) | 2007-08-16 |
NO20042209L (no) | 2004-07-28 |
US7304031B2 (en) | 2007-12-04 |
ES2381104T3 (es) | 2012-05-23 |
CA2465007C (en) | 2012-01-17 |
EA200400605A1 (ru) | 2004-08-26 |
CA2756610C (en) | 2015-08-25 |
CA2756610A1 (en) | 2003-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE542904T1 (de) | Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen | |
DE69829976D1 (de) | Verfahren zur trocknung von kompetenten zellen | |
DE59608743D1 (de) | Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation | |
ATE140960T1 (de) | Verfahren zur herstellung von zellen, die stabil integrierte fremde dns mit hoher kopiezahl enthalten, durch dieses verfahren hergestellte zellen und verwendung dieser zellen zur herstellung von durch diese fremde dns kodierten polypeptiden | |
DE69942636D1 (de) | Verfahren zur herstellung von glycoprotein mit menschlichem glycosylierungsbild | |
DE68921364T2 (de) | Verfahren zur Herstellung von Proteinen mittels rekombinanter DNA. | |
DE69818865D1 (de) | Verfahren zur herstellung von blockcopolymeren durch eine kontrollierte radikalpolymerisation mit dithioester | |
DE69434578D1 (de) | Expressionsvektoren die für bispezifische Proteine kodieren, und Verfahren zur Herstellung von biologisch-aktiven bispezifischen Fusionsproteine in Zellen von Säugertieren | |
DE3486179D1 (de) | Verfahren zur herstellung vielkettige polypeptide oder proteine. | |
ATE500331T1 (de) | Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden | |
DE68928532T2 (de) | Funktionelles, durch ein rekombinantes verfahren hergestelltes synthetisches proteinpolymer | |
ATE405676T1 (de) | Verfahren zur erzeugung doppelsträngiger dna mit einem 3'-einzelstranganteil und verwendungen dieser komplexe zur rekombination | |
ATE475708T1 (de) | Fusionskonstrukte und deren verwendung zur produktion von antikörpern mit erhöhter fc rezeptor bindungsaffinität und effektorfunktion | |
DE60205624D1 (de) | Methoden zur herstellung von im wesentlichen monodispersen polymermischungen mit polyethylenglykoleinheiten | |
NO911688D0 (no) | Neurotrophin-3, en ny neurotrofisk faktor relatert til neurovekstfaktor og hjerne-avledet neurotrofisk faktor. | |
DE69939268D1 (de) | Methoden zur aufreinigung von rekombinatem humanem erythropoietin aus zellkulturüberständen | |
DE69935978D1 (de) | Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung | |
ATE278024T1 (de) | Methode zur herstellung von rekombinanten zellen | |
ATE328102T1 (de) | Verfahren zur herstellung von proteine | |
DE3789678T2 (de) | Herstellung von erythropoietinproduzierenden Zellen und Verfahren zur Herstellung von Erythropoietin mit Verwendung dieser Zellen. | |
ATE506370T1 (de) | Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen | |
DE69902796T2 (de) | Verfahren zur reinigung von biomolekül- oder proteinkomplexen | |
DE69430975T2 (de) | Verfahren zur Herstellung von Proteinen | |
ATE532793T1 (de) | Verfahren zur herstellung von molekülen mit verminderter immunogenität | |
ATE435277T1 (de) | 18477, eine menschliche proteinkinase und deren verwendung |